Sep 10, 2019 / 03:10PM GMT
Vikram Purohit - Morgan Stanley, Research Division - Equity Analyst
All right. Thanks, everyone, for being here. We're going to get started. So I'm Vikram Purohit. I'm one of the biotech analysts here at Morgan Stanley. And before we get into it with Arcus, just need to let everyone know that for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures.
So with that, happy to have with me on the stage, Arcus Biosciences CEO, Terry Rosen. Terry, welcome.
Terry J. Rosen - Arcus Biosciences, Inc. - Co-Founder, Chairman & CEO
Thank you. Happy to be here.
Vikram Purohit - Morgan Stanley, Research Division - Equity Analyst
Yes. Happy to have you.
Terry J. Rosen - Arcus Biosciences, Inc. - Co-Founder, Chairman & CEO
Appreciate it.
Vikram Purohit - Morgan Stanley, Research
Arcus Biosciences Inc at Morgan Stanley Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot